Quarterly Statement Of Cash Flows

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7608021

Concept 2021-04-01 to
2021-06-30
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
1,329,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.